ArticleMayo Clinic proceedings2021

In Reply-Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis.

Carl J LaviePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.